Gut Hormones and Bone Remodeling Changes After Gastric Bypass Surgery
This study aims to observe how gut hormones and bone remodeling markers change in response to meals after gastric bypass surgery.
Data Collection
Collected from today forward - ProspectiveBody Weight+9
+ Bone Diseases
+ Metabolic Diseases
Case-Only
Examining characteristics of individuals with a disease in order to identify genetic or environmental factors contributing to the condition.Summary
Study start date: October 1, 2011
Actual date on which the first participant was enrolled.This study focuses on understanding the connection between the gut and bones. It looks at how meal-stimulated changes in blood levels of various hormones and markers related to intestinal growth and bone turnover are affected in patients undergoing gastric bypass surgery for obesity. The goal is to gain insights into how weight loss surgery might influence these hormones and markers, potentially impacting bone health and intestinal growth. Participants in this observational study will have their hormone levels measured through blood samples taken before and after gastric bypass surgery. The primary outcome of interest is the change in these gut hormones and bone markers in response to meals. These results will then be compared with changes in body weight and body composition, which will be measured using DEXA scanning.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.18 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Case-only
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 65 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Hospital of Roskilde-Koege, The University of Copenhagen
Koege, DenmarkOpen Hospital of Roskilde-Koege, The University of Copenhagen in Google Maps